Smith & Nephew hip resurfacing system recall
This article was originally published in The Gray Sheet
Executive Summary
Voluntary recall announced Aug. 16 includes 185 Smith & Nephew Birmingham Hip Resurfacing System implants. The recall cites incorrect packaging by a subcontractor that resulted in different sizes of acetabular cups being mixed together. S&N says its investigation has confirmed that the problem is confined to a "small number of batches" distributed in "a number" of countries, including the United States and the United Kingdom. The system was approved by FDA in 2006 1("The Gray Sheet" May 15, 2006, p. 8)...
You may also be interested in...
FDA Okays Smith & Nephew’s Birmingham Hip, But Orders Postmarket Studies
Smith & Nephew will be the first to offer hip resurfacing in the U.S. after FDA approved the firm's Birmingham system May 9
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.